Dr. Hornicek is an accomplished surgeon and researcher who specializes in treating patients with bone and soft tissue tumors.
Dr. Francis Hornicek graduated with a BA in biology and mathematics from Washington and Jefferson College. He earned his PhD in physics-biophysics from Georgetown University and his MD from the University of Pittsburgh. Dr. Hornicek completed his Orthopaedic Surgical Residency at the University of Miami and an Orthopaedic Oncology Fellowship at Massachusetts General Hospital and Children's Hospital Boston.
Dr. Hornicek serves as the Chief of the Orthopaedic Oncology Service, Co-Director of the Center for Sarcoma and Connective Tissue Oncology, Director of the MGH Stephan L. Harris Chordoma Center and Co-Leader of the Dana Farber/Harvard Cancer Center Sarcoma Group. He is an active educator of medical students, residents and fellows, and is involved in important cancer research.
Dr. Hornicek's clinical research interests include heterotopic ossification, allograft transplantation, immunotherapy, and outcome research for musculoskeletal tumors.
Dr. Hornicek's basic research efforts have focused on specific aspects of cell biology and more recently, molecular biology of sarcomas. Dr. Hornicek has also focused on the development of new chemotherapeutic drugs isolated from marine organisms for the treatment of sarcomas. This has led to clinical trials and patent applications. Dr. Hornicek plans to continue research efforts in the basic and clinical sciences and maintain integration with his clinical practice of orthopaedic oncology and tissue banking.
Yoon SS, Duda DG, Karl DL, Kim TM, Kambadakone AR, Chen YL, Rothrock C, Rosenberg AE, Nielsen GP, Kirsch DG, Choy E, Harmon DC, Hornicek FJ, Dreyfuss J, Ancukiewicz M, Sahani DV, Park PJ, Jain RK, Delaney TF. Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys. 2010 Oct 5.
Susa M, Choy E, Liu X, Schwab JH, Hornicek FJ, Mankin H, Duan Z. Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking. Mol Cancer Ther. 2010 Sep 29.
Devisetty K, Kobayashi W, Suit HD, Goldberg SI, Niemierko A, Chen YL, Raskin KA, Schwab JH, Springfield DS, Yoon SS, Hornicek FJ, Delaney TF. Low-Dose Neoadjuvant External Beam Radiation Therapy for Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys. 2010 Sep 21.
Tejwani A, Kobayashi W, Chen YL, Rosenberg AE, Yoon S, Raskin KA, Rosenthal DI, Nielsen GP, Hornicek FJ, Delaney TF. Management of acral myxoinflammatory fibroblastic sarcoma. Cancer. 2010 Aug 24.
Guo Y, Nemeth JA, O'Brien C, Susa M, Liu X, Zhang Z, Choy E, Mankin H, Hornicek FJ, Duan Z. Effects of Siltuximab on the IL-6 Induced Signaling Pathway in Ovarian Cancer. Clin Cancer Res. 2010 Aug 10.
MGH Hotline 08.06.10 This summer, one MGH physician traded his white coat for a suit jacket and his stethoscope for a wedding ceremony script when he officiated the wedding of one of his longtime patients.
Boston Magazine recognizes 134 MGH physicians on its annual list of top doctors in the Boston area.
The 4th Annual Sacral Tumor Study Group Conference, a collaboration with Massachusetts General Hospital, the Mayo Clinic and the Memorial Sloan-Kettering Cancer Center, took place on January 19, 2013.
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.